SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : PENNY GOLDEN STOCKS/10 BAGGERS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FRANK J CATALANO who wrote (232)10/26/2007 12:52:40 PM
From: Tadsamillionaire   of 241
 
FMTI Forbes Medi-Tech Boosts Rev Guidance On Strong Demand >FMTI

Forbes Medi-Tech Inc. (FMTI) has increased its revenue guidance to a range of C$8.75-C$9.25 million for fiscal 2007, based on the growth of contracted and forecasted tonnage for Reducol and other products for sale into the functional food and dietary supplement markets.
The Vancouver life-sciences company said it had previously issued revenue guidance of C$7.5-C$8 million.
It said its nutritional business "has grown substantially in the last two years, with a strong presence in the European marketplace and growing awareness in the U.S.. Factors included in the lift in revenue guidance are an increase in account activity and the sale of excess inventory, partially offset by the impact of the strengthening Canadian dollar against the U.S. dollar and the Euro. The sale of excess inventory has aligned our remaining inventory with forecasted demand."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext